Evaluation Value of Serum MiR-4299 and MiR-16-5p in Risk Stratification of Sepsis-Induced Acute Kidney Injury

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2022 Jul 18

PMID 35845963

Authors

Weiwei Pan

Junfeng Zhang

Luqi Hu

Zhiping Huang

Affiliations

Soon will be listed here.

Abstract

Objective: This study was designed to determine the evaluation value of serum miR-4299 and miR-16-5p in risk stratification of sepsis-induced acute kidney injury (SI-AKI).

Methods: A total of 115 sepsis patients were enrolled and assigned to the SI-AKI group ( = 64) or the sepsis-non-AKI group ( = 51) based on the occurrence of AKI, and 72 healthy individuals were enrolled. Fasting venous blood was sampled from every patient before admission, before therapy, and after therapy, followed by quantification of miR-4299 and miR-16-5p by fluorescence quantitative PCR. Receiver operating characteristic (ROC) curves were drawn to evaluate the value of serum miR-16-5p and miR-4299 expression in predicting SI-AKI, and Pearson's correlation analysis was performed to explore the associations of the two with Scr, Cys-C, and KIM-1.

Results: Cases with sepsis, especially SI-AKI, presented significantly downregulated serum miR-4299 and miR-16-5p. After therapy, the expression in them increased. The area under curve (AUC) of serum miR-4299 and miR-16-5p in the prediction value for early diagnosis of SI-AKI was 0.895 (95% CI: 0.839-0.951, cutoff value: 0.780) and 0.838 (95% CI: 0.767-0.909, cutoff value: 0.775), respectively, and the AUC of them in the prediction value for clinical efficacy on the disease were 0.733 (95% CI: 0.645-0.820, cutoff value: 1.115) and 0.776 (95% CI: 0.698-0.855, cutoff value: 1.125), respectively. Serum miR-16-5p and mIR-4299 were negatively correlated with Scr, Cys-C, and KIM-1, separately.

Conclusion: Both miR-16-5p and mIR-4299 are promising factors for early diagnosis of SI-AKI and dynamic evaluation of the efficacy on it.

Citing Articles

Systematic review of microRNAs in human acute kidney injury.

Douvris A, Vinas J, Akbari S, Tailor K, Lalu M, Burger D Ren Fail. 2024; 46(2):2419960.

PMID: 39477814 PMC: 11533245. DOI: 10.1080/0886022X.2024.2419960.

Retracted: Evaluation Value of Serum miR-4299 and miR-16-5p in Risk Stratification of Sepsis-Induced Acute Kidney Injury.

International B Biomed Res Int. 2024; 2023:9769478.

PMID: 38188820 PMC: 10769590. DOI: 10.1155/2023/9769478.

MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4.

Martino E, DOnofrio N, Balestrieri A, Mele L, Sardu C, Marfella R Cell Mol Biol Lett. 2023; 28(1):66.

PMID: 37587410 PMC: 10428548. DOI: 10.1186/s11658-023-00482-5.

Urinary microRNAs in sepsis function as a novel prognostic marker.

Han R, Li W, Tian H, Zhao Y, Zhang H, Pan W Exp Ther Med. 2023; 26(1):346.

PMID: 37383369 PMC: 10294602. DOI: 10.3892/etm.2023.12045.

References

Wu J, Li D, Li J, Yin Y, Li P, Qiu L . Identification of microRNA-mRNA networks involved in cisplatin-induced renal tubular epithelial cells injury. Eur J Pharmacol. 2019; 851:1-12. DOI: 10.1016/j.ejphar.2019.02.015. View

Wang Y, Zhang H . Regulation of Autophagy by mTOR Signaling Pathway. Adv Exp Med Biol. 2019; 1206:67-83. DOI: 10.1007/978-981-15-0602-4_3. View

Pietrukaniec M, Migacz M, Zak-Golab A, Olszanecka-Glinianowicz M, Chudek J, Dulawa J . Could KIM-1 and NGAL levels predict acute kidney injury after paracentesis? - preliminary study. Ren Fail. 2020; 42(1):853-859. PMC: 7472504. DOI: 10.1080/0886022X.2020.1801468. View

Liu Z, Yang D, Gao J, Xiang X, Hu X, Li S . Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis. Theranostics. 2020; 10(26):11963-11975. PMC: 7667674. DOI: 10.7150/thno.50093. View

Petejova N, Martinek A, Zadrazil J, Kanova M, Klementa V, Sigutova R . Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents-Pathophysiology and Biomarkers-A Review. Int J Mol Sci. 2020; 21(19). PMC: 7583998. DOI: 10.3390/ijms21197115. View

Teo S, Endre Z . Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol. 2017; 31(3):331-344. DOI: 10.1016/j.bpa.2017.10.003. View

Mehta R, Kellum J, Shah S, Molitoris B, Ronco C, Warnock D . Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11(2):R31. PMC: 2206446. DOI: 10.1186/cc5713. View

Connor K, Teenan O, Cairns C, Banwell V, Thomas R, Rodor J . Identifying cell-enriched miRNAs in kidney injury and repair. JCI Insight. 2020; 5(24). PMC: 7819746. DOI: 10.1172/jci.insight.140399. View

Peerapornratana S, Manrique-Caballero C, Gomez H, Kellum J . Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019; 96(5):1083-1099. PMC: 6920048. DOI: 10.1016/j.kint.2019.05.026. View

10.

Weng L, Zeng X, Yin P, Wang L, Wang C, Jiang W . Sepsis-related mortality in China: a descriptive analysis. Intensive Care Med. 2018; 44(7):1071-1080. DOI: 10.1007/s00134-018-5203-z. View

11.

Moledina D, Parikh C . Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine. Semin Nephrol. 2018; 38(1):3-11. PMC: 5753429. DOI: 10.1016/j.semnephrol.2017.09.002. View

12.

Yin J, Han B, Shen Y . RETRACTED: LncRNA NEAT1 inhibition upregulates miR-16-5p to restrain the progression of sepsis-induced lung injury via suppressing BRD4 in a mouse model. Int Immunopharmacol. 2021; 97:107691. DOI: 10.1016/j.intimp.2021.107691. View

13.

Hashemian S, Pourhanifeh M, Fadaei S, Velayati A, Mirzaei H, Hamblin M . Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis. Mol Ther Nucleic Acids. 2020; 21:51-74. PMC: 7272511. DOI: 10.1016/j.omtn.2020.05.012. View

14.

Ahmad S, Ahmed M, Hasan P, Sharma A, Bilgrami A, Manda K . Identification and Validation of Potential miRNAs, as Biomarkers for Sepsis and Associated Lung Injury: A Network-Based Approach. Genes (Basel). 2020; 11(11). PMC: 7696689. DOI: 10.3390/genes11111327. View

15.

Scala R, Schultz M, Bos L, Artigas A . New Surviving Sepsis Campaign guidelines: back to the art of medicine. Eur Respir J. 2018; 52(1). DOI: 10.1183/13993003.01818-2017. View

16.

Poston J, Koyner J . Sepsis associated acute kidney injury. BMJ. 2019; 364:k4891. PMC: 6890472. DOI: 10.1136/bmj.k4891. View

17.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

18.

Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B . The Epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional Survey. Crit Care Med. 2019; 48(3):e209-e218. DOI: 10.1097/CCM.0000000000004155. View

19.

Tang Y, Yang X, Shu H, Yu Y, Pan S, Xu J . Bioinformatic analysis identifies potential biomarkers and therapeutic targets of septic-shock-associated acute kidney injury. Hereditas. 2021; 158(1):13. PMC: 8052759. DOI: 10.1186/s41065-021-00176-y. View

20.

Xu G, Mo L, Wu C, Shen X, Dong H, Yu L . The regulatory axis is important for sepsis-induced acute kidney injury. Ren Fail. 2019; 41(1):955-966. PMC: 6830252. DOI: 10.1080/0886022X.2019.1669460. View